http://www.businessweek.com/news/2010-04-29/dendreon-rises-after-winning-approval-for-cancer-drug-update3-.html
Provenge will certainly be a pioneer in that area, Reichert said in an April 21 phone interview. The experience will definitely inform the clinical development programs of other companies and other products.
This article all but mentions PRR. Wooohooo!!!!
http://www.businessweek.com/news/2010-04-29/dendreon-rises-after-...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $399.6K | 1.329M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13902 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 29836 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |